Correction to: J Exp Clin Cancer Res 38, 143 (2019)
https://doi.org/10.1186/s13046-019-1149-4
Following publication of the original article [1], the authors identified minor errors in Fig. 2; specifically:
Fig. 2d: Incorrect images used for transwell assays of 5673 and T24 cells after shLINC00612 or shNC transfection (first column); correct images now used
Fig. 2.
LINC00612 promotes cell proliferation and invasion of BC cells in vitro. a Efficiency of LINC00612 expression in LINC00612 downregulated 5673 and T24 cells was evaluated via RT-qPCR. **P < 0.01. b Cell viability was measured via CCK8 assays. **P < 0.01. c, d Representative results of colony formation and transwell assays of 5673 and T24 cells after shLINC00612 or shNC transfection. e Efficiency of LINC00612 expression in LINC00612 overexpressed 5673 and T24 cells was evaluated via RT-qPCR. **P < 0.001. f Cell viability was measured via CCK8 assays. *P < 0.05. g, h Representative results of colony formation and transwell assays of 5673 and T24 cells after Lv-LINC00612 or Lv-NC transfection. N = 3 independent experiments
The corrected figure is given here. The correction does not have any effect on the final conclusions of the paper.
Footnotes
Liying Miao, Hong Yue Liu and Cuixing Zhou contributed equally to this work.
Reference
- 1.Miao L, Liu HY, Zhou C, et al. LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14. J Exp Clin Cancer Res. 2019;38:143. doi: 10.1186/s13046-019-1149-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

